How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS). Braz. J. Pharm. Sci. [Internet]. 2019 Nov. 29 [cited 2024 Apr. 27];55:e17197. Available from: https://revistas.usp.br/bjps/article/view/164524